Prof Martin SchwabUniversity of Zurich
Dr Schwab is Professor of Neuroscience, ETH Zurick and the University of Zurich and Director of the Brain Research Institute and the Centre for Neuroscience Zurich (ZNZ). He has made key contributions in the field of molecular mechanisms and therapies for spinal cord injuries. The anti-nogo antibodies that he discovered are currently at the clinical development stage at Novartis. He is the recipient of numerous awards for his contributions to basic and clinical science.
Back to overview